TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
DRUG

Bright Minds Biosciences Inc

Healthcare · Biotechnology

60.70$ +2.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Bright Minds Biosciences Inc (DRUG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 84 million CAD. Tick rows to compare them in a chart.

All figures in millions of CAD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DRUG
Line item 2019 2020 2021 2022 2023 2024 2025
0.2 0.9 20 12 6.9 6.1 84
0.1 0.9 20 12 6.8 6.0 84
0.1 0.8 20 12 6.7 5.7 83
0.1 0.8 20 12 6.7 5.7 83
0.1 0.2 0.0 0.1 0.4
0.0
0.1
0.0 0.0
0.0 0.0 0.0
0.0 0.2 0.6 1.5 0.3 0.6 2.4
0.0 0.2 0.6 1.5 0.3 0.5 2.3
0.1 0.1 0.1 0.1
0.0 0.1 0.6 1.2 0.2 0.4 1.7
0.1 0.7 19 11 6.6 5.5 82
-0.1 -0.6 -9.2 -24 -32 -34 -47
1.3 1.3 1.8 2.5 3.7 4.3 6.9

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?